Global Integrated CT‑Linac Market Strategic Research Report

Scope of the Report

The global Integrated CT‑Linac market size is predicted to grow from US$ 67.50 million in 2025 to US$ 2,632 million in 2032; it is expected to grow at a CAGR of 75.2% from 2026 to 2032.

Integrated CT‑Linac is a high‑end integrated radiotherapy device that deeply integrates a diagnostic CT imaging system and a radiotherapy linear accelerator onto one single platform.Its core characteristic is that the device enables a continuous closed‑loop workflow under the same treatment coordinate system, treatment couch and unified software, including diagnostic‑level CT image acquisition, tumor and organ‑at‑risk identification, patient positioning correction, dose evaluation, online adaptive replanning and precise irradiation.It thereby provides key technical support for high‑precision CT image‑guided radiotherapy, online adaptive radiotherapy and one‑stop radiotherapy.In 2025, the global sales volume of Integrated CT‑Linac was approximately 21 units, with an average transaction price of about 3.287 million US dollars per unit, and the gross profit margin was around 47%.

The Integrated CT‑Linac is currently transitioning from technology validation to high-end clinical adoption. Its market value lies not in replacing conventional linear accelerators across the board, but in reengineering workflows for highly complex radiotherapy.By integrating diagnostic-grade CT, patient positioning, dose evaluation, online adaptation, and treatment delivery onto a single platform, it aligns perfectly with the trends toward precision radiotherapy, one-stop workflows, and personalized treatment.In the foreseeable future, this market is more likely to be first adopted by leading cancer centers, university hospitals, and radiotherapy platforms pursuing differentiated capabilities, rather than experiencing rapid universal procurement.Its core competitiveness rests on high-quality imaging and closed-loop workflows. However, commercial expansion remains constrained by high capital investment, departmental workflow restructuring, software and quality assurance requirements, as well as competitive pressure from advanced CBCT adaptive systems and MR-Linac.Overall, the CT‑Linac represents a strategic niche segment characterized by high barriers, strong clinical drive, and a highly concentrated supplier base.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Integrated CT‑Linac market?

What factors are driving Integrated CT‑Linac market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Integrated CT‑Linac market opportunities vary by end market size?

How does Integrated CT‑Linac break out by Type, by Application?

This report presents a comprehensive overview of the global Integrated CT‑Linac market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• C‑arm Integrated CT‑Linac
• Ring‑shaped Integrated CT‑Linac

Segment by Application

• Online Adaptive Radiotherapy
• One‑Stop Radiotherapy

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Integrated CT‑Linac market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Online Adaptive Radiotherapy, One‑Stop Radiotherapy evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact